CORSINI, ALBERTO
CORSINI, ALBERTO
Dipartimento di Scienze Farmacologiche e Biomolecolari
Hypercholesterolemia and inflammation—Cooperative cardiovascular risk factors
2024 A. Gallo, W. Le Goff, R.D. Santos, I. Fichtner, S. Carugo, A. Corsini, C. Sirtori, M. Ruscica
Impact of cigarette smoke on vascular smooth muscle cell senescence
2024 C. Rossi, M. Venturin, C. Battaglia, A. Corsini, S. Bellosta
Lipid-lowering approaches to manage statin-intolerant patients
2024 M. Ruscica, A. Bertoletti, C. Gobbi, C.R. Sirtori, S. Carugo, A. Corsini
Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study
2024 M. Ruscica, C. Macchi, S. Gandini, D. Macis, A. Guerrieri-Gonzaga, V. Aristarco, D. Serrano, M. Lazzeroni, A.S. Rizzuto, A. Gaeta, A. Corsini, M. Gulisano, H. Johansson, B. Bonanni
Drug interactions in cardiology: focus on statins and their combination with other lipid-lowering drugs
2024 S. Bellosta, A. Corsini
PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?
2024 L. Barbieri, G. Tumminello, I. Fichtner, A. Corsini, R.D. Santos, S. Carugo, M. Ruscica
Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review
2024 N. Ferri, M. Ruscica, S. Fazio, A. Corsini
Vescicole extracellulari nel contesto dell'aterosclerosi = Extracellular vesicles in atherothrombosis
2024 M. Ruscica, A. Rizzuto, C. Macchi, I. Fichtner, S. Carugo, A. Corsini
Lipoprotein(a) and the atherosclerotic burden – Should we wait for clinical trial evidence before taking action?
2024 I. Fichtner, C. Macchi, A.S. Rizzuto, S. Carugo, A. Corsini, M. Ruscica
Characterization of replicative and doxorubicin-induced senescence models in vascular smooth muscle cells
2023 C. Rossi, M. Venturin, C. Macchi, M. Ruscica, A. Corsini, C. Battaglia, S. Bellosta
Smooth Muscle Cell Phenotypic Switch Induced by Traditional Cigarette Smoke Condensate: A Holistic Overview
2023 L. Bianchi, I. Damiani, S. Castiglioni, A. Carleo, R. De Salvo, C. Rossi, A. Corsini, S. Bellosta
Hypocholesterolaemic treatment in coronary unit: from statins to anti PCSK9 therapies and bempedoic acid
2023 N. Ferri, A. Corsini, M. Ruscica
Fixed Combination for the Treatment of Dyslipidaemia
2023 N. Ferri, M. Ruscica, R.D. Santos, A. Corsini
LDL Cholesterol Variability Impacts the Prognosis of Patients with Chronic Ischemic Heart Disease: A Real-World Italian Experience
2023 P. Faggiano, M. Ruscica, S. Bettari, A. Cherubini, S. Carugo, A. Corsini, G. Barbati, A. Di Lenarda
Mechanism of bempedoic acid induced cholelithiasis: A role for statins to limit this adverse effect?
2023 N. Ferri, A. Corsini
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events
2023 E. Raschi, M. Casula, A.F.G. Cicero, A. Corsini, C. Borghi, A. Catapano
PURPL and NEAT1 Long Non-Coding RNAs Are Modulated in Vascular Smooth Muscle Cell Replicative Senescence
2023 C. Rossi, M. Venturin, J. Gubala, A. Frasca, A. Corsini, C. Battaglia, S. Bellosta
Pollution from fine particulate matter and atherosclerosis: A narrative review
2023 C. Macchi, C.R. Sirtori, A. Corsini, P. Mannuccio Mannucci, M. Ruscica
Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study
2023 M. Ruscica, C. Macchi, A. Giuliani, A.S. Rizzuto, D. Ramini, M. Sbriscia, S. Carugo, A.R. Bonfigli, A. Corsini, F. Olivieri, J. Sabbatinelli
Updates in Small Interfering RNA for the Treatment of Dyslipidemias
2023 S. Carugo, C.R. Sirtori, G. Gelpi, A. Corsini, L. Tokgozoglu, M. Ruscica